Bryan Truman Hunt - Jan 17, 2023 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief Financial Officer
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Jan 17, 2023
Transactions value $
-$54,163
Form type
4
Date filed
1/19/2023, 04:00 PM
Previous filing
Dec 5, 2022
Next filing
Feb 24, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Sale -$24.7K -2.06K -1.45% $12.00 139K Jan 17, 2023 Direct F1
transaction HCAT Common Stock Sale -$29.5K -2.35K -1.69% $12.53 137K Jan 18, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.